Fintepla Available in Germany as Add-on Seizure Therapy

Fintepla Available in Germany as Add-on Seizure Therapy

285756

Fintepla Available in Germany as Add-on Seizure Therapy

After its approval in Europe in December, Fintepla (fenuramine) now is  commercially available in Germany as an add-on treatment for seizures associated with Dravet syndrome in patients 2 and older, the therapy’s developer, Zogenix, recently announced. “With the launch of FINTEPLA in Germany, physicians and caregivers here can now access an urgently needed, effective and generally well-tolerated new treatment option to help reach their goals of reducing the devastating seizures and improving outcomes and quality…

You must be logged in to read/download the full post.